Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2018

01-04-2018 | Correspondence

Incidental Discovery of Anti-IH in a Patient Planned for Caesarean Section and it’s Repercussions

Authors: Lin-Nan Shao, Wen-Qian Song, Ni Wang, Wei-Jian Yu, Shi-Hang Zhou

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2018

Login to get access

Excerpt

A 27-year-old pregnant woman, 37 weeks pregnant, tested positive during antibody screening at Maternity and Child Healthcare Hospital. She had one child born by caesarian operation and no history of transfusions. She was referred to our blood center to reserve blood for caesarean operation. The blood groups of her and her husband are listed in Table 1. At room temperature (RT), forward grouping was A1B group with D positive. Reverse grouping results were negative for A cells, weak agglutination (w +) for B cells and 2 + agglutination for O cells. Autocontrol and direct antiglobulin (IgG + C3d) test were both negative. Antibody screening results of the commercially available panel (Sanquin, Makropanal 16, Lot: 8000236600) are showed in Table 1. Further investigation revealed that by immediate spin, the antibody was strongly reactive against A2 RBCs but not against O and B cord RBCs, suggesting that it is anti-IH. In order to identify whether the plasma contains other specific antibodies, we randomly selected five donors’ RBCs for each blood group of A, B and AB respectively and reacted with plasma: group AB donors’ RBCs were negative and group A and B donors’ RBCs were consistent with the agglutination intensity seen in reverse grouping. We treated the patient’s plasma with 2-mercaptoethanol (2-ME) and no agglutination was seen in panel cells with saline and antiglobulin media. Cross-match tests with seven randomly chosen group AB units were compatible with saline and antiglobulin media. Fortunately, caesarean operation was successful without blood transfusion and the child was healthy.
Table 1
Blood grouping of the couple and antibody screen result of this pregnant woman
   
−A
−B
−D
A1 cells
B cells
O cells
A2 cells
O cord
B cord
−A1
−H
−E
−e
−C
−c
−M
−N
−P1
−Lea
−Leb
−I
Husband
IS
4+
4+
4+
NT
NT
NT
2+
4+
4+
4+
4+
4+
4+
4+
3+
Wife
IS
4+
4+
4+
w+
2+
2+
4+
1+
4+
4+
4+
4+
4+
4+
4+
3+
 
4 °C
NT
NT
NT
1+
1+
4+
3+
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
 
37 °C
NT
NT
NT
w+
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
 
Cell panel
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
         
 
IS
2+
2+
2+
2+
2+
2+
2+
2+
2+
2+
2+
2+
2+
2+
2+
2+
         
 
37 °C
w+
w+
w+
w+
w+
w+
w+
w+
w+
w+
w+
w+
w+
w+
w+
w+
         
IS immediate spin at room temperature, NT not test
Literature
1.
go back to reference Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P et al (2016) Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients. Transfusion 56:1828–1833CrossRefPubMed Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P et al (2016) Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients. Transfusion 56:1828–1833CrossRefPubMed
2.
go back to reference Boonyasampant M, Weitz IC, Kay B, Boonchalermvichian C, Liebman HA, Shulman IA (2015) Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion 55:2398–2403CrossRefPubMed Boonyasampant M, Weitz IC, Kay B, Boonchalermvichian C, Liebman HA, Shulman IA (2015) Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion 55:2398–2403CrossRefPubMed
3.
go back to reference Irani MS, Richards C (2011) Hemolytic transfusion reaction due to anti-IH. Transfusion 51:2676–2678CrossRefPubMed Irani MS, Richards C (2011) Hemolytic transfusion reaction due to anti-IH. Transfusion 51:2676–2678CrossRefPubMed
4.
go back to reference Darabi K, Makar RS (2008) Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Transfusion 48:964–968CrossRefPubMed Darabi K, Makar RS (2008) Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Transfusion 48:964–968CrossRefPubMed
5.
go back to reference Campbell SA, Shirey RS, King KE, Ness PM (2000) An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease. Transfusion 40:828–831CrossRefPubMed Campbell SA, Shirey RS, King KE, Ness PM (2000) An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease. Transfusion 40:828–831CrossRefPubMed
Metadata
Title
Incidental Discovery of Anti-IH in a Patient Planned for Caesarean Section and it’s Repercussions
Authors
Lin-Nan Shao
Wen-Qian Song
Ni Wang
Wei-Jian Yu
Shi-Hang Zhou
Publication date
01-04-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0891-z

Other articles of this Issue 2/2018

Indian Journal of Hematology and Blood Transfusion 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine